Background
==========

We tested the hypothesis that a tissue engineering approach using chemoattractant molecules will allow *in situ*recruitment of human bone marrow mesenchymal stem cells (MSC) to sites of degenerated articular cartilage.

Objective
=========

The aim of our ongoing study is to characterize molecules that are involved in chondrogenesis and chemotaxis of MSC.

Methods
=======

Human bone marrow aspirates were used to isolate MSC. The culture homogeneity was verified by FACS analysis (CD14^-^, CD34^-^, CD45^-^, CD105^+^, CD166^+^). For differentiation, MSC were centrifuged to form high-density cultures and different TGFs were added. Chondrogenesis was documented by Alcian blue, type II collagen staining and by real-time PCR of marker genes. Chemotaxis was analyzed by chemokine receptor analyses and transwell chamber assays.

Results
=======

The histological staining showed BMP-2 promotes differentiation along the chondrogenic lineage. Matrix formation was comparable to MSC stimulated with TGF-β~3~. The results suggest a synergistic stimulation on chondrogenic differentiation with BMP-2 and TGF-β~3~. Differentiation was further demonstrated by the induction of type II collagen, aggrecan, SOX-9 and link protein on the gene expression level. Furthermore, for the first time, expression of chemokine receptors of all four chemokine subfamilies was proven by RT-PCR and subsequent sequence analysis, as well as at the protein level using specific antibodies. The chemotactic activity in 24-transwell chemotaxis chambers was demonstrated for, for example, SDF1a.

Conclusion
==========

These findings demonstrate that chondrogenic development of MSC is inducible by different TGF-β~3~superfamily growth factors including BMP-2. Additionally, MSC express chemokine receptors relevant for chemotaxis or *in situ*recruitment for cartilage regeneration.
